Bristol-Myers Squibb Profit Margin

Bristol-Myers Squibb's profit margin stands at 18.46% as of September 2026. That compares with 12.57% in the prior-year period — up 46.9% year over year. That is below the Healthcare sector average of 19.13%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Bristol-Myers Squibb reported 18.46% in profit margin versus 12.57% a year earlier — a 46.9% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Bristol-Myers Squibb sits lower the Healthcare benchmark (19.13%) with a profit margin of 18.46%. That is roughly 3.5% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 18.46% for Bristol-Myers Squibb means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Bristol-Myers Squibb's profit margin evolved across reporting periods, while the comparison chart places BMY next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.